<DOC>
	<DOC>NCT01281774</DOC>
	<brief_summary>The purpose of this study is to assess the safety, tolerability and pharmacokinetics of CSL112 in healthy volunteers after multiple infusions.</brief_summary>
	<brief_title>A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy males and females aged 18 years to less than 55 years Body weight 50kg or greater Body mass index (BMI) between 18 and 42.0 kg/m2 Evidence of a clinically significant medical condition, disorder or disease Evidence of hepatobiliary disease Any clinically relevant abnormal laboratory test result Evidence or history of alcohol or substance abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>